More information: Reut Shor et al, Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2025.1455 ...

Source Reference: Shor R, et al "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol.2025.1455.

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Neovascular Age-Related Macular Degeneration Noemi Lois, MD, PHD Disclosures Compr Ophthalmol Update. 2004;5 (3) Therapies Under Investigation Anti-Vascular Endothelium Growth Factor.

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

TOPLINE: Dutch patients with neovascular age-related macular degeneration (AMD) who initiated bevacizumab achieved greater long-term improvements in visual acuity than patients in ...

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

FYB203 has been approved by the US FDA and UK Medicines and Healthcare products Regulatory Agency for the treatment ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has ...

It’s the less common form of age-related macular degeneration (the other form is dry AMD), accounting for 10 to 15 percent of cases, according to the American Macular Degeneration Foundation. [1] ...

Neovascular age-related macular degeneration, also called wet AMD, can lead to blindness. Experts said people taking GLP-1s shouldn't panic, but the results should encourage more monitoring of the ...